Regal Partners Ltd Reduces Holdings in Inspire Medical Systems, Inc. $INSP

Regal Partners Ltd reduced its position in Inspire Medical Systems, Inc. (NYSE:INSP) by 35.7% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 135,767 shares of the company’s stock after selling 75,537 shares during the quarter. Regal Partners Ltd’s holdings in Inspire Medical Systems were worth $7,003,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. CWM LLC boosted its stake in Inspire Medical Systems by 216.1% during the 4th quarter. CWM LLC now owns 354 shares of the company’s stock worth $33,000 after purchasing an additional 242 shares during the last quarter. Havemeyer Place LP acquired a new stake in shares of Inspire Medical Systems in the fourth quarter valued at about $39,000. V Square Quantitative Management LLC purchased a new position in shares of Inspire Medical Systems in the fourth quarter worth about $40,000. Smartleaf Asset Management LLC boosted its position in Inspire Medical Systems by 84.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock worth $42,000 after acquiring an additional 205 shares during the last quarter. Finally, Daiwa Securities Group Inc. boosted its position in Inspire Medical Systems by 38.7% during the second quarter. Daiwa Securities Group Inc. now owns 466 shares of the company’s stock worth $60,000 after acquiring an additional 130 shares during the last quarter. Hedge funds and other institutional investors own 94.91% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on INSP. UBS Group assumed coverage on shares of Inspire Medical Systems in a research note on Tuesday. They set a “sell” rating and a $39.00 price objective for the company. Mizuho decreased their target price on shares of Inspire Medical Systems from $70.00 to $55.00 and set an “outperform” rating on the stock in a research note on Tuesday, May 5th. Robert W. Baird lowered their target price on Inspire Medical Systems from $63.00 to $50.00 and set a “neutral” rating on the stock in a report on Tuesday, May 5th. Truist Financial upped their price target on Inspire Medical Systems from $50.00 to $54.00 and gave the company a “hold” rating in a research report on Thursday, July 16th. Finally, Stifel Nicolaus cut their price target on Inspire Medical Systems from $70.00 to $65.00 and set a “buy” rating for the company in a report on Tuesday, May 5th. One investment analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, thirteen have issued a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, Inspire Medical Systems currently has a consensus rating of “Hold” and an average target price of $73.28.

Inspire Medical Systems Trading Up 2.0%

Shares of INSP opened at $51.93 on Wednesday. Inspire Medical Systems, Inc. has a 12-month low of $38.91 and a 12-month high of $147.03. The firm has a 50-day moving average price of $45.61 and a 200 day moving average price of $56.43. The firm has a market capitalization of $1.50 billion, a P/E ratio of 11.57, a P/E/G ratio of 5.16 and a beta of 0.71.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings data on Monday, May 4th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.38. Inspire Medical Systems had a net margin of 14.33% and a return on equity of 10.35%. The firm had revenue of $204.58 million during the quarter, compared to analysts’ expectations of $200.04 million. During the same period last year, the business earned $0.10 earnings per share. Inspire Medical Systems’s revenue was up 1.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. Equities research analysts predict that Inspire Medical Systems, Inc. will post 0.93 earnings per share for the current fiscal year.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.